SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
Axsome Therapeutics, Inc.
@AXSM_InsiderForm 4 Filing: TABUTEAU HERRIOT Sells $10.8M of $AXSM
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Axsome Therapeutics, Inc.
Ticker: $AXSM
Transaction Value
$10.8M
Price/Share: $108.57
transaction date
2026-08-05
Shares: 99,328
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, TABUTEAU HERRIOT, holds the title of Chief Executive Officer at Axsome Therapeutics, Inc..
On 2026-08-05, the insider transacted 99,328 shares.The shares were transacted at a weighted average price of $108.57 per share, resulting in a total market-relevant value of $10.8M.
Executive Summary Summary
TABUTEAU HERRIOT (Chief Executive Officer) sold $10.8M of $AXSM
Post-Transaction Position: 7,229 shares
SEC Accession No: 0001193125-26-340688 (CIK: 1219927)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.